Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash from Operations (2016 - 2026)

Conmed filings provide 17 years of Cash from Operations readings, the most recent being 13472000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 67.56% to 13472000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 142627000.0, a 20.49% decrease, with the full-year FY2025 number at 170689000.0, up 2.23% from a year prior.
  • Cash from Operations hit 13472000.0 in Q1 2026 for Conmed, down from 46335000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 56395000.0 in Q4 2023 to a low of 11598000.0 in Q4 2022.
  • Median Cash from Operations over the past 5 years was 29134000.0 (2025), compared with a mean of 29990705.88.
  • Biggest five-year swings in Cash from Operations: crashed 1272.87% in 2023 and later soared 856.98% in 2024.
  • Conmed's Cash from Operations stood at 11598000.0 in 2022, then skyrocketed by 586.25% to 56395000.0 in 2023, then dropped by 23.15% to 43338000.0 in 2024, then rose by 6.92% to 46335000.0 in 2025, then plummeted by 70.92% to 13472000.0 in 2026.
  • The last three reported values for Cash from Operations were 13472000.0 (Q1 2026), 46335000.0 (Q4 2025), and 53686000.0 (Q3 2025) per Business Quant data.